[HTML][HTML] MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI insight, 2023 - ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) is an
inflammatory demyelinating CNS condition characterized by the presence of MOG …
inflammatory demyelinating CNS condition characterized by the presence of MOG …
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI …, 2023 - pubmed.ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating CNS condition characterized by the presence of MOG …
inflammatory demyelinating CNS condition characterized by the presence of MOG …
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI …, 2023 - mayoclinic.elsevierpure.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating CNS condition characterized by the presence of MOG …
inflammatory demyelinating CNS condition characterized by the presence of MOG …
[HTML][HTML] MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI …, 2023 - Am Soc Clin Investig
Myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) is an
inflammatory demyelinating CNS condition characterized by the presence of MOG …
inflammatory demyelinating CNS condition characterized by the presence of MOG …
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity.
SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI Insight, 2023 - europepmc.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating central nervous system condition characterized by the presence …
inflammatory demyelinating central nervous system condition characterized by the presence …
[引用][C] MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
SS Yandamuri, B Filipek, AH Obaid, N Lele… - insight, 2023 - europepmc.org
Myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) is a
disease entity defined by the presence of circulating MOG autoantibodies. The core clinical …
disease entity defined by the presence of circulating MOG autoantibodies. The core clinical …
[HTML][HTML] MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI …, 2023 - Am Soc Clin Investig
Myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) is a
disease entity defined by the presence of circulating MOG autoantibodies. The core clinical …
disease entity defined by the presence of circulating MOG autoantibodies. The core clinical …